JARVIS OLSEN: Open Payments
NPI 1194149146 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,746 in 73 payments from 21 companies in 2025. Trend: 2023 $1,039 · 2024 $1,607 · 2025 $1,746
Food & beverage: $1,613Education: $133
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 9 | $305 |
| Axsome Therapeutics, Inc. | 8 | $182 |
| Abbott Laboratories | 4 | $180 |
| PFIZER INC. | 8 | $171 |
| Amgen Inc. | 5 | $126 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $118 |
| ABBVIE INC. | 5 | $105 |
| Novo Nordisk Inc | 5 | $87 |
| Astellas Pharma US Inc | 4 | $76 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $74 |
Products named: XYWAV, Sunosi, FREESTYLE LIBRE 3, JARDIANCE, Veozah, LUMRYZ, OTEZLA, PREVNAR 20.
Industry payments across NV — which companies pay providers there.
